THERAtRAME
Liège, BE · Founded 2022 · 16 employees on LinkedIn · 2 known investors
Find your way into THERAtRAME
Sign up to see every warm intro you have to THERAtRAME
- Paths you didn't know you had: your email and LinkedIn already hold routes to the THERAtRAME team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
THERAtRAME is a biotech company developing tRNA-targeting therapies for cancer patients, particularly those resistant to current treatments. The company translates research on tRNA biology and modifications into first-in-class drug candidates to address therapeutic resistance and tumor progression.
Founders & leadership
THERAtRAME was founded in 2022 by Francesca Rapino and Pierre Close.
FR

Investors · 2
Frequently asked questions
- What does THERAtRAME do?
- THERAtRAME is a biotech company developing tRNA-targeting therapies for cancer patients, particularly those resistant to current treatments. The company translates research on tRNA biology and modifications into first-in-class drug candidates to address therapeutic resistance and tumor progression.
- Who founded THERAtRAME?
- THERAtRAME was founded by Francesca Rapino, Pierre Close in 2022.
- Who are THERAtRAME's investors?
- THERAtRAME's investors include Wallonie Entreprendre, Qbic Fund.
- Where is THERAtRAME headquartered?
- THERAtRAME is headquartered in Liège, BE.



